AJP - Heart Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 287: H1149-H1159, 2004. First published April 29, 2004; doi:10.1152/ajpheart.00060.2004
0363-6135/04 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/3/H1149    most recent
00060.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loughrey, C. M.
Right arrow Articles by MacEachern, K. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loughrey, C. M.
Right arrow Articles by MacEachern, K. E.

Comparison of Ca2+ release and uptake characteristics of the sarcoplasmic reticulum in isolated horse and rabbit cardiomyocytes

C. M. Loughrey,1 G. L. Smith,2 and K. E. MacEachern1

1Institute of Comparative Medicine, University of Glasgow Veterinary School, University of Glasgow, Glasgow G61 1QH; and 2Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, United Kingdom

Submitted 22 January 2004 ; accepted in final form 23 April 2004


    ABSTRACT
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Both the cardiac action potential duration (APD) (0.6–1 s) and resting heart rate (30–40 beats/min) in the horse are significantly different from humans and smaller mammals, including the rabbit. This would be anticipated to have consequences for excitation-contraction (EC) coupling and require adaptation of the individual processes involved. The sarcoplasmic reticulum (SR) is one of the main components involved in EC coupling. This study examines and compares the activity of this organelle in the horse with that of the rabbit. In particular, the study focuses on SR Ca2+ release via the Ca2+ release channel/ryanodine receptor (RyR2) and Ca2+ uptake via the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) pump. Isolated cardiomyocytes from both horse and rabbit hearts were permeabilized, bathed in a mock intracellular solution, and exposed to a specified [Ca2+]. Rabbit cardiomyocytes exposed to 260 nM [Ca2+] produced spontaneous Ca2+ release and propagated Ca2+ waves. Horse cells failed to produce Ca2+ waves; instead, only local release in the form of Ca2+ sparks was evident. However, at 550 nM [Ca2+], Ca2+ waves were produced in both species. Ca2+ waves were four times less frequent yet ~1.5 times greater in amplitude in the horse compared with the rabbit. Ca2+ wave velocity was comparable between the species. The reason for this disparity in Ca2+ wave characteristics is unknown. Separate measurements of oxalate-supported Ca2+ uptake into the SR suggest that both horse and rabbit cardiomyocytes have comparable levels SERCA activity. The possible reasons for the observed differences in SR Ca2+ release between the horse and rabbit are discussed.

cardiac; waves; equine


EXCITATION-CONTRACTION (EC) coupling within ventricular cardiomyocytes is the process whereby cellular depolarization results in a relatively small influx of Ca2+ across the sarcolemma that in turn causes a larger release of Ca2+ from the sarcoplasmic reticulum (SR). This Ca2+-induced Ca2+ release (14, 15) subsequently leads to myofilament activation and cellular contraction (3). The same sequence of events is thought to apply in heart cells across the mammalian species ranging from hearts as small as cells from the mouse [heart rate (HR) 600–750 beats/min at rest] to those as large as humans (HR 60–100 beats/min) and horses (HR 30–40 beats/min). However, whereas data concerning the details of EC coupling is available for small mammals and human myocardium, only limited data has been reported for larger mammals, including the equine species.

One important feature of EC coupling is the duration of the ventricular muscle action potential. The equine action potential duration (APD) anticipated from electrocardiographic measurements would suggest a value of 0.6–1.0 s (11, 44) an estimate which is similar to recent in vitro measurements made on equine cardiac tissue (16). This value is considerably higher than that from the human, pig, dog, rabbit, and guinea pig, which, despite the wide range of resting heart rates, display comparable APD (0.2–0.35 s) (5, 21, 35, 53, 54). In smaller mammals, maintained depolarization causes elevated intracellular [Ca2+] concentration ([Ca2+]i) and an increased incidence of spontaneous Ca2+ release (2). These events activate transient inward currents that increase the probability of triggered arrhythmias (25, 29) in particular, early afterdepolarizations, which occur during repolarization, and delayed afterdepolarizations. The latter phenomena are also observed in heart failure where APD prolongation is also a consistent electrophysiological observation (4, 22, 40, 42).

Another feature of the equine heart is the slow heart rate experienced at rest (30–40 beats/min). Studies on isolated myocardium/myocytes from mammals, including the human, rabbit, and hamster, have shown that a direct imposition of a slow heart rate by pacing at slower than normal (resting) heart rates results in a prolonged APD (21, 46, 53). With the exception of the rat and mouse, this pacing can lead to diminution of the intracellular Ca2+ transient and decreased fractional shortening (28, 36, 37, 45). These studies therefore indicate that a slowing in heart rate and accompanying prolongation of APD cannot be simply imposed on the basic EC coupling mechanism without consequences for the electrical and mechanical stability of the heart.

In this study, we have compared the behavior of the SR from the horse with that of the rabbit. The marked differences observed in dynamic SR function between the two species highlight a possible modification of equine SR Ca2+ release and uptake, which may decrease the potential for arrhythmogenic activity while ensuring that the rise of intracellular Ca2+ is adequate to activate contractile proteins at low resting heart rates.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Equine Single Ventricular Cardiomyocyte Isolation

Equine hearts were obtained from horses with life-threatening or career-ending disorders unrelated to the cardiovascular system. A 7 x 7-cm section of midmyocardium from the left ventricle was cut into 1–3 mm3 of tissue. These were washed and resuspended in the following solution (in mM): 120 NaCl, 20 HEPES, 5.4 KCl, 0.52 NaH2PO4, 3.5 MgCl2, 6 H2O, 10 2,3-butanedione monoxime (BDM), 1 EGTA, and 11.1 glucose, pH 7.25 (20–21°C). An aliquot of tissue was then gently broken up further with an Ultraturrax homogenizer for 2 s at minimal speed (5,000 rpm). The cellular suspension, containing single-cell equine cardiomyocytes, was then filtered (250 µm mesh), washed, and resuspended in 1 ml of the above solution. The process was repeated with further aliquots of tissue until an adequate number of single cells was achieved. The final cellular suspension obtained was washed and resuspended in Krebs-Henseleit solution without the addition of BDM until use.

Rabbit Single Ventricular Cardiomyocyte Isolation

New Zealand White rabbits (2–2.5 kg) underwent humane euthanasia with an intravenous injection of 500 IU heparin and an overdose of sodium pentobarbitone (100 mg/kg). The animal care and handling protocols followed NIH and our institution’s animal care guidelines. The hearts were rapidly excised and cannulated onto a Langendorff perfusion column via the aorta. The hearts were perfused retrogradely at a perfusion rate of 25 ml/min (37°C), initially with 150 ml of Krebs-Henseleit solution. Thereafter, the hearts were perfused with 75 ml of Krebs-Henseleit solution supplemented with 0.66 mg/ml collagenase (type 1, Worthington) and 0.04 mg/ml protease (type XIV, Sigma) for 2 min. At ~2 min, the enzyme solution was collected and 50 µM CaCl2 was added to the recirculating perfusate. Finally, at ~6 min the heart was perfused with 50 ml of 0.1% Krebs-Henseleit solution containing 0.1% bovine serum albumin and 50 µM CaCl2. The left ventricle was dissected free from the heart on the column, cut into chunks, and incubated (37°C) for 1 h in Krebs-Henseleit solution (no added Ca2+). The cell suspensions obtained at the end of the incubation period were filtered (250 µm mesh) back into Krebs-Henseleit solution at a concentration of ~1 x 105 cell/ml. Unlike the preparation of equine myocytes, BDM was not used in rabbit cell isolation.

Studying SR Function in Horse and Rabbit Cardiomyocytes

[Ca2+]i <200 nM generally leads to the production of spontaneous whole cell SR Ca2+ release-Ca2+ waves. These events initiate in one area of the cell and subsequently propagate to the remainder. Their production is a function of the 1) SR Ca2+ release channel/RyR2, 2) Ca2+ uptake into the SR via the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) pump, and 3) SR luminal control including intra-SR buffering. The cells were then permeabilized to characterize and compare these Ca2+ events in both species without the influence of sarcolemmal ionic transport mechanisms.

Cell Permeabilization for Confocal Measurements

Cardiomyocytes (horse and rabbit) were allowed to settle onto the coverslip at the base of a small (300-µl volume) bath. {beta}-Escin (Sigma) was acutely applied from a freshly prepared stock solution to the cell suspension within the 300-µl bath to give a final concentration of 0.1 mg/ml. Permeabilization was ascertained using confocal microscopy to monitor the entry of fluorophore into the cell (0.5–1 min).

Solutions for Production of Spontaneous Ca2+ Waves Within Permeabilized Cells

Permeabilized cells were perfused with a mock intracellular solution with the following composition (in mM): 100 KCl, 5 Na2ATP, 10 disodium creatine phosphate (Na2CrP), 5.5 MgCl2, 25 HEPES, and 0.05 K2EGTA, pH 7.0 (20–21°C). The equilibrium concentrations of metal ions in the calibration solutions were calculated using a computer program (React; G. L. Smith) with known affinity constants for H+, Ca2+, and Mg2+ for EGTA (47) and for ATP and CrP (13). Corrections for ionic strength, details of pH measurement, allowance for EGTA purity, and the principles of the calculations are detailed elsewhere (39). Free Mg2+ was calculated to be 0.9 mM (verified by MgFura measurements). The [Ca2+] in the perfusing solution was varied by the addition of known amounts of 1 M CaCl2 stock solution. The fluorescent Ca2+ indicator Fluo-3 (Molecular Probes) was added to the solution to give a nominal final concentration of 10 µM. All other chemicals were supplied by Sigma.

Laser Scanning Confocal Fluo-3 Fluorescence Measurements in Free Solution and Permeabilized Cardiomyocytes

The Ca2+ sensitivity of Fluo-3 in free solution was measured using a series of Ca2+-buffered solutions (10 mM EGTA) based on the mock intracellular solution described above. Fluo-3 inside the permeabilized cardiomyocyte has a Ca2+ affinity indistinguishable from that of free solution (558 nM) (31).

Ca2+ Wave Measurements in Permeabilized Cardiomyocytes

Confocal line-scan images were recorded using a Bio-Rad Radiance 2000 confocal system. Fluo-3 in the perfusing solution was excited at 488 nm and measured >500 nm (HQ500LP emission filter) using epifluorescence optics of a Nikon Eclipse inverted microscope with a Fluor x60 water objective lens (1.2 numerical aperture; Plan Apochromat). The 3-mW Kr laser was set to 12% power, and the gain on the photomultiplier tube set to 25%. Iris diameter was set at 1.9 providing an axial (z) resolution of ~0.9 µm and X-Y resolution of ~0.5 µm based on full-width half-maximal amplitude measurements of images of 0.175 µm fluorescent beads (Molecular Probes). Data were acquired in a line-scan mode at 2 ms/line and the pixel dimension was 0.3 µm (512 pixels/scan; zoom = 1.4). The scanning laser line was oriented parallel with the long axis of the cell and placed approximately equidistant between the outer edge of the cell and the nucleus/nuclei, to ensure the nuclear area was not included in the scan line. The LaserScan (Bio-Rad) software saved the data as a series of image files each containing 30,000 line scans (i.e., 1 min of continuous recording). An experimental record typically comprised 4–5 line-scan image files; these were reviewed off-line and a single intracellular region (20 pixels wide) was selected based on the earliest events in the majority of Ca2+ waves. This ensured that any movement artifact after the increase in [Ca2+] did not affect the estimation of peak [Ca2+]. Simultaneous measurements were also taken from the extracellular solutions using the same method. Average background fluorescence values (Fbg) were subtracted from the fluorescence measurements to obtain accurate values of fluorophore-associated fluorescence. Permeabilized cells Fbg = 5.29 ± 0.43 (n = 6) and extracellular Fbg = 3.56 ± 0.21 (n = 6) (30).

Measurements of SR Ca2+ Uptake Rates in Cardiac Protein Homogenates

A sample of either horse or rabbit midmyocardium weighing 1 g (±1%) was placed into 5 ml of the following homogenization buffer and kept on ice: 100 mM KCl, 25 mM HEPES, 0.05 mM EGTA, 1 mM MgCl2, 1 mM DTT, 5 mg/ml leupeptin, and 10 mg/ml aprotonin. Protein concentration (total protein in mg/g of tissue) was assayed in triplicate using a standard Coomassie blue protein reagent and spectrophotometer (595 nm) absorption measurements. No differences in the yield of total protein were observed between rabbit myocardium (95.7 ± 2.1 mg protein/g wet wt; n = 10) and equine myocardium (89.6 ± 6.7; n = 6). The concentration of protein used for the functional measurements was 2 mg of protein/ml. This concentration of protein contributes a negligible amount of Ca2+ buffering to the solution (20). This was suspended in 2 ml of mock intracellular solution as for the permeabilized cells (see above). {beta}-Escin (0.1 mg/ml; Sigma) was added, and the homogenate was gently spun down with the use of a hand centrifuge (5 g, 1 min). The pellet was resuspended in the above mock intracellular solution. The free [Mg2+] was 0.9–1 mM in all solutions. This was calculated as for the above solutions with the use of a computer program (React, G. L. Smith). Fura-2 (10 µM; Molecular Probes) was used to monitor the [Ca2+] within the cuvette with the use of a dual-wavelength spectrophotometer (Cairn Research). Oxalate (10 mM; Sigma) was added to maintain low and constant levels of intra-SR [Ca2+]. Ruthenium Red (RuR) (3 µM) was used to block Ca2+-efflux via the ryanodine receptor. RuR can inhibit SERCA and quench the fluorescence signal from Fura-2 (24). However, at 3 µM RuR, the effects of RuR on SERCA are minimal and quench appeared to affect the fluorescence at both excitation wavelengths equally without affecting the Km of Fura for Ca2+. The time course of the decrease of [Ca2+] within the cuvette was monitored in response to the addition of an aliquot of CaCl2. All measurements were made at room temperature (20–22°C). At the end of a series of uptake measurements on an aliquot of cells, the Fura-2 signal was calibrated using two standard solutions: <10 nM [Ca2+], 5 mM EGTA, and 370 nM [Ca2+] (10 mM EGTA). In a separate set of measurements, a range of free [Ca2+]s was used to measure the affinity of Fura-2 for Ca2+ under our experimental conditions, a Kd value of 110 ± 20 nM was obtained, close to that measured in another study (18).

The time course of Ca2+ uptake was used to assess SR Ca2+ uptake capacity by: 1) conversion of free [Ca2+] to total [Ca2+] assuming the major Ca2+ buffer in solution was EGTA, 2) differentiation of the total [Ca2+] with respect to time and correcting the Ca2+ uptake rate for the amount of homogenate protein. The value of instantaneous Ca2+ uptake rate was plotted against the corresponding free [Ca2+] to generate the sigmoid relationship shown in Fig. 6B. The resultant data were fitted to a logistic curve using Origin (OriginLab) to obtain a maximal rate of Ca2+ uptake (Vmax) and Km for each data set.



View larger version (23K):
[in this window]
[in a new window]
 
Fig. 6. Comparison of the Ca2+ uptake characteristics of permeabilized horse and rabbit ventricular cardiomyocytes. A: individual experiment of sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA)-mediated Ca2+ uptake in permeabilized cardiomyocytes. The black trace is the time course of cuvette [Ca2+] (cardiac homogenate) measured using Fura-2 (10 µM). The addition of 66 µM total [Ca2+] causes a rapid [Ca2+] rise, and subsequent decline because of SR transport. The gray trace is the change in total [Ca2+] calculated from known Ca2+ buffers in the solution. B: the rate of Ca2+ uptake (d[Ca2+]total/dt) vs. [Ca2+]. The gray trace is the best fit to d[Ca2+]total/dt = Vmax/{1 + ([Ca2+]/Km)2}. C: typical comparison of horse and rabbit rate uptake. D: mean values of maximal uptake rate (Vmax) (a) and Km (b), respectively, for both species are shown. The data from rabbit myocytes isolated in 2,3-butanedione monoxime BDM (10 mM) are also shown on the same graph (rabbit BDM).

 
Statistics

Data were expressed as means ± SE. Comparisons were performed by using the unpaired Student's t-test, and differences were considered significant when P < 0.05.


    RESULTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Anatomic and Hemodynamic Data for Horse and Rabbit

Figure 1 shows photographs of typical adult hearts from the horse, rabbit, and mouse. As indicated by Table 1, the typical body weights, heart weights, and cardiac outputs are ~200-fold larger in the horse compared with the rabbit. The heart rate is, however, almost five times lower in the horse compared with the rabbit and hence the scaled cardiac output (in ml·kg body wt–1·min–1) is comparable between the two species.



View larger version (97K):
[in this window]
[in a new window]
 
Fig. 1. A comparison of the dimensions of the intact heart between three differently sized species. Typical photographs of hearts from three species demonstrating the difference in organ size among mammalian species.

 

View this table:
[in this window]
[in a new window]
 
Table 1. Comparison of average anatomic and hemodynamic values for the rabbit and horse

 
Ventricular Cardiomyocyte Size

Figure 2 shows typical transmission images of single isolated cardiomyocytes from horse, rabbit, and mouse hearts. Strikingly, whereas the intact whole horse heart, shown in Fig. 1, is almost five times larger in every aspect compared with the rabbit heart (and a similar relationship exists between the rabbit and mouse heart), the cardiomyocytes from each species are of similar dimensions and cell length was not significantly different (P > 0.05). Although cell width was greater in the horse (P < 0.05), the extent was small [cell length: 118.6 ± 4.1 vs. 116.0 ± 5.7 µm; cell width 25.1 ± 1.0 µm vs. 28.7 ± 0.6 µm, rabbit (n = 24) vs. horse (n = 82), respectively].



View larger version (96K):
[in this window]
[in a new window]
 
Fig. 2. A comparison of the dimensions of the single ventricular cardiomyocyte between three differently sized species. Transmission images of typical single cardiomyocytes from the horse (A), rabbit (B), and mouse (C). Note the similarity in cell dimensions among the species despite the vast difference in the intact heart sizes shown in Fig. 1.

 
Measurements of Ca2+ Waves in Permeabilized Cardiomyocytes

Figure 3 shows the protocol used to initiate Ca2+ waves within both horse and rabbit cardiomyocytes and is described in detail in our previous study (30). Because of the presence of Fluo-3 (10 µM) in the perfusing solution, the fluorescence signal recorded from line-scan images of the cell contains signals from both intracellular and extracellular compartments. The extracellular signal (black trace; Fig. 3A) resembles therefore the changes in fluorescence due to solution changes, and the intracellular fluorescence signal (gray trace; Fig. 3A) relates to the cytoplasmic changes of [Ca2+], which occur in the cell as a result of these solution changes. Increasing [Ca2+]i from 40 to 565 nM within this equine cardiomyocyte (as indicated above the fluorescence trace in Fig. 3) initiated a series of Ca2+ waves recorded as transient increases in fluorescence at regular intervals at the intracellular site. The delay between the increased cytosolic [Ca2+] and the first Ca2+ wave is caused by a period of net SR Ca2+ uptake and diffusion of [Ca2+] into the cell. No obvious differences in this delay between the two species were apparent. The frequency of Ca2+ waves was constant after ~15 s, suggesting a new steady SR Ca2+ content was achieved. At the point indicated, the perfusing solution was changed to one containing 375 nM free [Ca2+] (buffered by 10 mM EGTA). The high EGTA concentration effectively clamped the [Ca2+], buffering Ca2+ release, and uptake by the SR. The [Ca2+] was subsequently reduced to <1 nM [Ca2+] by perfusion with 10 mM EGTA solution (no added Ca2+) and then to 33 µM [Ca2+] by perfusion with 10 mM EGTA solution (not shown). The fluorescence signal in the last three solutions (10 mM EGTA) were used to convert the fluorescence signal into [Ca2+] as shown in Fig. 3B.



View larger version (20K):
[in this window]
[in a new window]
 
Fig. 3. Protocol to produce sarcoplasmic reticulum (SR) Ca2+ waves within permeabilized ventricular cardiomyocytes. A: record of fluorescence signal taken from line-scan images from a permeabilized horse cardiomyocyte [black trace is extracellular signal (EC) and gray trace is intracellular signal (IC)], including elevating the [Ca] in the perfusate from 40 to 565 nM [Ca2+] (50 µM EGTA and 10 µM Fluo-3). Subsequently, the cardiomyocyte was perfused with a 375 and <1 nM Ca2+ (*total [EGTA] = 10 mM, 10 µM Fluo-3) as indicated above the trace. B: using the calibration solutions in A, the fluorescence signal can be converted to [Ca2+] as shown in B. C: average fluorescence signal of the last four Ca2+ waves shown in B (open box) (IC, gray trace) and the corresponding extracellular [Ca2+] marker (EC, black dotted trace), which was calculated by averaging the extracellular trace in B (long open box).

 
As shown in Fig. 3B, there appeared to be a variation in peak [Ca2+] of the Ca2+ wave. While this may represent differences in Ca2+ release from the SR, the changes in peak [Ca2+] cannot be easily distinguished from the variation due to the noise associated with the photomultiplier signal. This latter form of error was reduced by averaging the fluorescence signals from a number of waves (Fig. 3C) before converting to [Ca2+] (Fig. 3D). The minimum [Ca2+] reached in this cell occurred during the interwave period, as shown in the averaged signal in Fig. 3C, the value was ~150 nM. The highest Ca2+ concentration reached occurred at the peak of the Ca2+ wave and again using the average trace in Fig. 3C was ~3.5 µM. A similar protocol was performed in both rabbit and equine cardiomyocytes across the range of [Ca2+] from 40 to 260 nM (n = 8 cells from 3 different rabbits and n = 8 cells from 4 different horses) and from 40 nM to 565 nM [Ca2+] (n = 8 cells from 3 different rabbits and n = 5 cells from 2 different horses).

Comparison of Ca2+ Wave Characteristics in Horse and Rabbit

Ca2+ wave frequency and velocity. Whereas Ca2+ waves were initiated in rabbit cardiomyocytes at a [Ca2+] of 250–270 nM with a frequency of 0.16 ± 0.02 waves/s (n = 9), no Ca2+ waves were evident at this [Ca2+]i in the horse (n = 9) (Fig. 4D,a). However, if the [Ca2+] was subsequently increased to 540–560 nM, Ca2+ waves were produced from cardiomyocytes from both species (Fig. 4A). Figure 4A,b and c, shows single Ca2+ waves from both horse and rabbit at this higher [Ca2+]. Although in ~80% of cells, the point of initiation of the Ca2+ wave was in the same region of the cell during a 120-s line-scan image, ~20% of cells showed variation in the region of cell in which the Ca2+ wave began (Fig. 4A,a). This feature of Ca2+ waves was similar between the two species. Ca2+ waves appear similar at the point of initiation; however, the duration of release was markedly elevated and prolonged in the horse relative to the rabbit. The [Ca2+] signal trace of a series of Ca2+ waves from the horse and rabbit in Fig. 4C, a and b, respectively, emphasize this observation. It can also be seen that at these higher [Ca2+]s (550 nM) Ca2+ waves in the horse occurred with a significantly lower frequency (0.12 ± 0.01 waves/s; n = 25) compared with the rabbit (0.48 ± 0.10 waves/s; n = 6), as shown in Fig. 4D,b (P < 0.05).



View larger version (34K):
[in this window]
[in a new window]
 
Fig. 4. Comparison of Ca2+ wave frequency and velocity in the horse with that of rabbit. A,a: three sequential Ca2+ waves from the same equine cardiomyocyte to illustrate that the point of initiation of the wave was not always in the same region of the cell. Bottom, line-scan images of typical Ca2+ waves from the horse (b) and rabbit (c). The area covered by the dotted lines in a denotes the 20-pixel region used to analyze Ca2+ waves and provide the traces shown in Fig. 3. B: mean velocity of Ca2+ waves in the horse and rabbit at 550 nM [Ca2+] calculated from the average gradient of several Ca2+ waves from each cell. C: higher time resolution of the [Ca2+] of Ca2+ waves from both the horse (a) and rabbit (b). D: provides mean data for Ca2+ wave frequency between horse and rabbit at (a) 260 nM [Ca2+] and (b) 550 nM [Ca2+] (*P < 0.05). Note that no Ca2+ waves were produced when the SR was exposed to an intracellular [Ca2+] of 260 nM.

 
The wave front was considered the midpoint of the upstroke. The gradient of a 50-pixel region of the wave front in the line-scan image (as shown in Fig. 4A,a, by the dashed lines) was used to calculate Ca2+ wave velocity. An average velocity (5–10 waves for the rabbit and 3–5 waves for the horse) was calculated for each cell. The wave velocity between the two species (114.5 ± 9.1 µm/s, n = 21, horse; 127.7 ± 14.0 µm/s, n = 5, rabbit) was not significantly different (Fig. 4B).

Ca2+ wave maximum and minimum values. Figure 5A shows that characteristic profile of spontaneous SR Ca2+ release taken from an average of a series of Ca2+ waves from a single cardiomyocyte in both the horse (black trace) and rabbit (gray trace). The average maximum and minimum [Ca2+] values from a number of cells is presented in Fig. 5B. It can be seen that the maximum peak of Ca2+ release is significantly greater in the horse (3.28 ± 0.26 µM, n = 5) compared with the rabbit (2.04 ± 0.19 µM, n = 6, P < 0.05). The peak [Ca2+] in equine cells, represent fluorescence values close to Fmax for Fluo-3. Therefore, to verify the peak [Ca2+] observed in equine cells, a limited set of measurements were made using Fluo-5F, a dye with a lower Ca2+ sensitivity (30). In two experiments, the peak [Ca2+] was 3.25 and 3.75 µM. These values were in close agreement with the mean obtained using Fluo-3 and confirm the differences in peak [Ca2+] observed with Fluo-3 between the two species.



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 5. Comparison of the Ca2+ wave profile and amplitude in the horse with that of rabbit. A,a: averaged Ca2+ wave from the horse and rabbit to demonstrate the difference in profile and amplitude of Ca2+ waves from both species. A,b: the rise of the [Ca2+] on an expanded time scale. B: average peak (maximum) and lowest (minimum) [Ca2+] of the averaged Ca2+ wave from several cells (*P < 0.05). C: average wave duration at 50% amplitude for both the horse and rabbit (*P < 0.05).

 
In contrast, the minimum interwave [Ca2+]i is not significantly different between the two species (182 ± 16 nM, n = 5; horse; 201 ± 23 nM, n = 6; rabbit). All values in Fig. 5 were produced at the higher [Ca2+] of 550 nM, where both mean and extracellular [Ca2+]i were equivalent. Figure 5C provides information regarding the profile of the wave, in particular, the wave duration at 50% of the wave amplitude. As illustrated in Fig. 5A, Ca2+ waves have an approximately three times longer duration (at 50% amplitude) compared with the rabbit [1,161 ± 212 ms, horse; 383 ± 84 ms, rabbit (P < 0.05)].

SR Ca2+ wave release characteristics. To characterize Ca2+ release from the SR, the rate of rise and fall of the Ca2+ wave was assessed at two set [Ca2+]s (1.0 and 1.5 µM). These measurements were performed on the average Ca2+ wave of each cell as shown in Fig. 3C. The rate of rise of Ca2+ during the wave in the rabbit was significantly greater than the horse at both [Ca2+] as shown in Table 2 and Fig. 5A. A similar observation was made during the rate of fall. The duration of the rise phase between 600 nM and peak [Ca2+] was also assessed. The duration of rise was nearly fourfold greater in the horse compared with the rabbit (Table 2) (P < 0.05). A value of 600 nM was used as the starting point for the measurement because the mean [Ca2+]o was ~560 nM.


View this table:
[in this window]
[in a new window]
 
Table 2. SR Ca2+ wave release characteristics in horse and rabbit cardiomyocytes

 
SR Ca2+ uptake characteristics. Because SR Ca2+ release is related to SR Ca2+ uptake an assessment of SERCA activity was performed. As shown in Fig. 6, oxalate-supported Ca2+ uptake was measured in permeabilized cardiac homogenate protein. The rate of uptake of [Ca2+] in the cuvette after addition of an aliquot of CaCl2 (66 µM) was the same in both horse and rabbit (Fig. 6C). No Ca2+ uptake occurred in the presence of thapsigargin (5 µM), and thus the signal was analyzed assuming uptake was SERCA mediated. A quantitative description of SERCA activity was obtained by calculating the changes of total [Ca2+] based on the known Ca2+-buffering capacity of the extracellular solution (Fig. 6A). Differentiation of the total [Ca2+] signal reveals the rate of Ca2+ uptake that can be plotted against the associated free [Ca2+] to obtain a sigmoidal relationship (Fig. 6B). This relationship was fitted with a logistic curve to estimate the free [Ca2+] that generated half of the maximal Ca2+ uptake rate (Km) and the value of Vmax. Figure 6D shows mean values of Km and Vmax. It can be seen that no significant difference in SERCA activity exists between horse and rabbit SR. In a subset of experiments, rabbit myocytes were dissociated in solutions containing 10 mM BDM. After cell isolation, BDM was washed off and the cells treated in an identical fashion to the control cells. The parameters for SERCA mediated Ca2+ uptake derived from these cells were not significantly different from rabbit myocytes without BDM treatment (Fig. 6D). This indicates that exposure to BDM during the tissue preparation phase does not irreversibly affect SERCA in rabbit myocytes.


    DISCUSSION
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
To our knowledge, this is the first report investigating the properties of SR in single isolated cardiomyocytes from the horse. In particular, we have explored how the SR adapts to Ca2+ overload. We show that permeabilized horse cardiomyocytes produce Ca2+ waves that propagate in a similar fashion to other species, including the rabbit. However, to initiate these events, a much higher elevation of cytoplasmic [Ca2+]i is required. One important methodological issue is the use of BDM in the preparation of equine but not rabbit cardiac tissue. BDM is known to have completely reversible effects on the activity of SERCA and RyR (1, 49). To further demonstrate this point, BDM was used in the rabbit cell dissociation in a limited number of experiments (n = 4). The parameters for SERCA-mediated uptake (Vmax and Km) were not significantly different from the control group. On this basis, the use of BDM in the preparation of equine tissue is unlikely to irreversibly affect SR function.

The Use of Ca2+ Waves to Study SR Function

This study has focused on SR Ca2+ release via RyR2 and SR Ca2+ uptake via SERCA. Many authors (7, 10, 43, 52, 55) have used Ca2+ wave characteristics to assess SR function. The data obtained from these studies have been fundamental to our understanding of EC coupling within ventricular cardiomyocytes. The importance of studying Ca2+ waves becomes even more pertinent in a species that shows a prolonged APD and low resting heart rate, i.e., the horse. The greater period of time held at more positive potentials during the prolonged action potential would be anticipated to lead to a greater influx Ca2+ via the Na+/Ca2+ exchanger (outward mode). This would lead to an elevation of [Ca2+]i, a higher SR Ca2+ content, and the production of spontaneous Ca2+ waves. These events increase the probability of arrhythmogenic transient inward currents, which are incompatible with normal heart function.

Measuring Ca2+ Wave Characteristics in Permeabilized Cells

Ca2+ wave characteristics are sensitive to changes in [Ca2+]i (9, 30). For this reason, equine and rabbit Ca2+ wave characteristics were measured and compared in permeabilized cardiomyocytes. The permeabilized cell has the advantage that [Ca2+]i can be accurately calibrated and standardized. Previous studies (31, 32) have established that SR Ca2+ release events are indistinguishable from those observed in intact cells and are regulated by known modulators of RyR2 activity (Ca2+-calmodulin and cADP ribose).

Ca2+ Wave Characteristics at 260 nM [Ca2+]i

Ca2+ waves in rabbit cardiomyocytes were apparent at ~260 nM [Ca2+]i (frequency ~0.16 waves/s). However, even during prolonged test periods (3–4 min), Ca2+ waves in isolated equine cardiomyocytes were not observed. It is conceivable that these events occur in horse cardiomyocytes at frequencies <0.005 waves/s. However, linear extrapolation of the relationship between [Ca2+]i and wave frequency in the rabbit suggest that the free [Ca2+]i would need to be as low as 20 nM before waves occurred at such low frequencies (30). It is unlikely that Ca2+ overload occurs at such [Ca2+]i. The lowest frequency Ca2+ waves reported have been observed in a study of intact rat myocardium (23). These events were termed "sporadic" Ca2+ waves and occurred at a frequency of 0.02–0.2 waves/s. These waves would have been observed during the long test period used in this study. Therefore, it would seem valid to conclude that the threshold for spontaneous Ca2+ waves in horse ventricular cardiomyocytes is higher than that for rabbit.

Localized SR Ca2+ release originating from a single cluster of RyR2s is called a Ca2+ spark (8). The spontaneous production of these events is a function of both cytoplasmic and luminal [Ca2+] (7, 33). Ca2+ wave initiation is thought to be the result of both the "temporal and spatial summation of Ca2+ sparks" in a discreet area of the cell (7). This process leads to recruitment of Ca2+ release from sufficiently sensitized adjacent clusters and subsequent wave propagation. Ca2+ sparks were observed at 250 nM [Ca2+]i in both rabbit and horse cardiomyocytes (results not shown). Therefore, SR Ca2+ release events with the potential to initiate Ca2+ waves were present in both species, but while conditions were sufficient for wave propagation in the rabbit, they were not sufficient in the horse. Therefore, to produce propagating Ca2+ waves in equine cells, the [Ca2+]i was raised.

Ca2+ Wave Characteristics at 560 nM [Ca2+]i

The main characteristic of equine Ca2+ waves at 560 nM [Ca2+]i was their low frequency and large amplitude (relative to rabbit waves at the same free [Ca2+]i). The factors determining the frequency of spontaneous SR Ca2+ release are complex. One view is that the system can be described in terms of having a simple threshold [Ca2+] value with which the SR triggers Ca2+ release (43). Another view, which has been examined in detail, involves luminal control (34). This group suggests that high luminal [Ca2+] increases the open probability of RyR2. Thus both approaches suggest that SR luminal [Ca2+] is the main determinant of Ca2+ wave frequency. A longer time between Ca2+ waves could be attributed to a slower rise of luminal Ca2+ or a relative insensitivity of RyR2 to luminal Ca2+. Whereas this investigation does not come to any definitive conclusions as to why equine SR Ca2+ release occurs with such low frequency when exposed to similar [Ca2+]s as the rabbit, it is useful to consider the various possibilities.

SR Ca2+ Uptake

If the rate of Ca2+ uptake is slowed then the time taken to reach threshold for Ca2+ release will increase, and the frequency will subsequently decrease. The comparative investigation of SERCA Ca2+ uptake rates (per milligram of cell protein) in rabbit and equine myocardial homogenates found no significant difference between the two species. One possible artifact in these measurements is the differential retrieval of cell protein from rabbit and equine myocardium. However, based on the similar cellular dimensions and comparable protein retrieval values (see MATERIALS AND METHODS), there is no evidence that retrieval of cell protein from rabbit and equine myocardium is markedly different. It is therefore unlikely an artifact is obscuring a differential in SERCA expression. Furthermore, it has been demonstrated that a reduction of SERCA-mediated Ca2+ uptake rate by application of 2,5-di-tert-butyl hydroquinone, while reducing the frequency of Ca2+ waves does not affect the peak [Ca2+] (19). Hence, whereas this parameter may have been a plausible explanation for a decrease in wave frequency it would not have explained the concurrent increase in Ca2+ wave amplitude.

SR Ca2+ Capacity and Release

If the capacity of the SR for Ca2+ in horse cardiac cells is greater than rabbit, a longer time will be taken for the SR to fill before the threshold for spontaneous Ca2+ release is reached and next wave produced. A main determinant of the functional size of the SR for Ca2+ is calsequestrin: an intra-SR Ca2+ binding protein (Kd ~0.6 mM) (6, 51). A recent study using adenoviral-mediated overexpression (~4-fold) of calsequestrin in rat ventricular cardiomyocytes showed that functional recharging of SR Ca2+ stores is slowed due to the increase in intra-SR buffering (51). This resulted in a decrease in the frequency of repetitive spontaneous Ca2+ sparks. The increased SR Ca2+ content in these cells also led to an increase in size of spontaneous (Ca2+ sparks) and stimulated SR Ca2+ release. This finding is similar to the situation found in equine Ca2+ waves, which are less frequent but larger in amplitude. However, no data have been published specifically relating to the relationship between SR buffering capacity and Ca2+ waves.

Overexpression of calsequestrin acts to stabilize the free intra-SR Ca2+ concentration adjacent to the luminal side of RyR and limits luminal Ca2+-dependent deactivation of RyR (51). In doing so, a prolonged rise time of Ca2+ release is observed (51). This is also the case in the equine Ca2+ wave (relative to the rabbit) and could be explained by an increased concentration of horse intra-SR buffer. This is further supported by the striking difference observed between the Ca2+ wave profile in the rabbit and horse (Fig. 5C). As soon as the rabbit peak [Ca2+] is reached, Ca2+ declines. The horse wave duration, however, remains elevated for a prolonged time (Fig. 5, A and C). Ca2+ wave decline is a function of Ca2+ uptake via SERCA, Ca2+ release via RyR2, and diffusion away from the cell. This suggests a larger Ca2+ release from equine SR during the wave. The larger Ca2+ wave amplitude in the horse relative to the rabbit supports this hypothesis (Fig. 5B). A very similar profile of SR Ca2+ release is also observed in stimulated transients and spontaneous Ca2+ sparks when intra-SR Ca2+ buffering is increased by overexpression of calsequestrin (51). Attempts to quantify the amount of calsequestrin in equine SR relative to the rabbit were unsuccessful due to the lack of a specific anti-equine antibody.

Whereas the duration of the rising phase of SR Ca2+ release is related to the inactivation of the release process, the rate of rise is related to the activation of RyR2 (51). An unusual finding is the decreased rate of Ca2+ release (at 1 and 1.5 µM) in the horse relative to the rabbit. A greater flux of Ca2+ through the RyR2 would expect to be achieved at a faster rate (51). Terentyev et al. (51) found no significant difference between the maximal rates of rise of Ca2+ release during stimulated transients overexpressing calsequestrin compared with control. The authors suggested that this may be due to slowed diffusion of Ca2+ through the luminal space and hence slowed transit of Ca2+ through open channels in cells overexpressing calsequestrin (51). If the horse has an increase in intra-SR buffering, then this may also be the case.

RyR Sensitivity

A decrease in sensitivity of RyR2 to cytosolic Ca2+ could explain a lower frequency Ca2+ wave, because the threshold for SR Ca2+ release would increase and therefore the time taken to reach it. This conclusion is supported by previous work (43) using tetracaine to reduce the Ca2+ sensitivity of RyR2. Tetracaine caused lower frequency but larger SR Ca2+ waves that propagate at comparable velocities to Ca2+ waves under control conditions. The propagation of Ca2+ waves within cardiomyocytes occurs by saltatory propagation between clusters of RyR2 (26). Ca2+ wave velocity is proportional to the amplitude of SR Ca2+ release but inversely related to the distance between firing sites and the threshold for SR Ca release (26). The peak amplitude of the Ca2+ wave in the horse relative to the rabbit is larger and should therefore result in a faster wave. However, no significant difference in wave velocity between the two species was observed. The mean value of 114 ± 6 µm/s (n = 21) for horse Ca2+ waves is similar to the values reported by other studies in rat and rabbit (23, 27, 30, 50, 52) and faster than others (7, 48). This lack of difference in Ca2+ wave velocity may be due to differences in distance between SR Ca2+ release sites. Assuming release sites are clustered at the T-tubule junction, preliminary measurements suggest that inter-T-tubular distance is similar between the two species. Alternatively, a decrease in equine RyR sensitivity may be responsible. This would increase the threshold for SR Ca2+ release and as explained above, lower Ca2+ wave frequency, yet produce larger Ca2+ waves, such as those observed in equine cardiomyocytes. Further measurements are required to confirm this conclusion.

Implications for Intact Cell and Whole Heart of Equine Species

To initiate Ca2+ waves in horse cardiomyocytes, an approximately threefold increase in resting [Ca2+]i (assuming a resting Ca2+ of 150 nM) is required, compared with only a ~0.3-fold increase in the rabbit. Furthermore, when Ca2+ waves in the horse do occur, they are more than four times less frequent than rabbit at the same [Ca2+]i (0.117 vs. 0.484 waves/s in horse and rabbit, respectively). The long diastolic periods without potentially arrhythmogenic spontaneous SR Ca2+ release allows at least 4–5 Ca2+ transients to be stimulated at an HR of 30 beats/min (0.5 Hz) without the potential for a Ca2+ wave to be produced, the SR presumably being partially depleted at each transient. This decreased propensity for spontaneous SR Ca2+ release at a resting [Ca2+] is beneficial in a species with a prolonged APD and an increased propensity for SR Ca2+ overload.

The horse has the ability to increase HR almost 10-fold (from ~24 to ~240 beats/min) during strenuous exercise (38). This is compared with humans, who may only achieve an approximately threefold rise of resting heart rate. This degree of tachycardia in the horse is likely to bring more Ca2+ into the SR via voltage-dependent L-type Ca2+ channels and would increase the propensity for Ca2+ overload if efflux from the cells were not sufficient to match Ca2+ influx. The adaptations required for this balance of sarcolemmal fluxes in the horse can only be examined using electrophysiological measurements within intact cells and are highly desirable experiments that need to be performed in light of the results of this investigation. A previous study (16) has assessed the characteristics of the various potassium channels required for cellular repolarization within equine cardiomyocytes. The conclusion reached in this study was that cardiac repolarization in the horse resembles that in humans (16). Therefore, changes in repolarization characteristics are unlikely to be the major adaptive change necessary to reduce the incidence of triggered arrhythmias that may occur during prolonged APD. This further emphasizes the significance of SR adaptation that may occur in the horse compared with other species when faced with such a prolonged APD.

Future Directions

Although the majority of animal models of heart failure result in a variation of function/expression of proteins that regulate cellular Ca2+ homeostasis, a commonality among most models is SR dysfunction (12). This ultimately leads to decreased contractility. The ultimate goal of cardiac therapeutic investigations has been to find agents that increase the inotropy of the heart by increasing SR Ca2+ content and Ca2+ release for a given trigger. However, this has often been impeded by the problematic side effect of SR Ca2+ overload and subsequent arrhythmias. The equine species apparently has the capacity for a high SR Ca2+ content and release but at the same time a reduced incidence of potentially arrhythmogenic Ca2+ waves in conditions of Ca2+ overload. Molecular cardiology studies within the equine species may therefore provide us with invaluable insights into potential therapeutic strategies for both human and animal heart failure.


    GRANTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
This study was supported by an Engineering and Physical Sciences Research Council studentship and the Faculty of Veterinary Medicine, Glasgow University (to C. M. Loughrey).


    ACKNOWLEDGMENTS
 
We kindly acknowledge the expert technical assistance of Aileen Rankin and Anne Ward.


    FOOTNOTES
 

Address for reprint requests and other correspondence: G. L. Smith, West Medical Bldg., Univ. of Glasgow, Glasgow G12 8QQ, UK (E-mail: g.smith{at}bio.gla.ac.uk).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Adams W, Trafford AW, and Eisner DA. 2,3-Butanedione monoxime (BDM) decreases sarcoplasmic reticulum Ca content by stimulating Ca release in isolated rat ventricular myocytes. Pflügers Arch 436: 776–781, 1998.[CrossRef][ISI][Medline]
  2. Bers DM. Excitation-Contraction Coupling and Cardiac Contractile Force. Amsterdam, The Netherlands: Kluwer, 2001.
  3. Bers DM. Cardiac-excitation-contraction coupling. Nature 415: 198–205, 2002.[CrossRef][Medline]
  4. Beuckelmann DJ, Nabauer M, and Erdmann E. Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res 73: 379–385, 1993.[Abstract/Free Full Text]
  5. Botchway AN, Turner MA, Sheridan DJ, Flores NA, and Fry CH. Electrophysiological effects accompanying regression of left ventricular hypertrophy. Cardiovasc Res 60: 510–517, 2003.[Abstract/Free Full Text]
  6. Cala SE and Jones LR. Rapid purification of calsequestrin from cardiac and skeletal muscle sarcoplasmic reticulum vesicles by Ca2+-dependent elution from phenyl-sepharose. J Biol Chem 258: 11932–11936, 1983.[Abstract/Free Full Text]
  7. Cheng H, Lederer MR, Lederer WJ, and Cannell MB. Calcium sparks and [Ca2+]i waves in cardiac myocytes. Am J Physiol Cell Physiol 270: C148–C159, 1996.[Abstract/Free Full Text]
  8. Cheng H, Lederer WJ, and Cannell MB. Calcium sparks: elementary events underlying excitation contraction coupling in heart muscle. Science 262: 740–744, 1993.[Abstract/Free Full Text]
  9. Diaz ME, Trafford AW, O'Neill SC, and Eisner DA. A measurable reduction of s.r. Ca content follows spontaneous Ca release in rat ventricular myocytes. Pflügers Arch 434: 852–854, 1997.[CrossRef][ISI][Medline]
  10. Diaz ME, Trafford AW, O'Neill SC, and Eisner DA. Measurement of sarcoplasmic reticulum Ca2+ content and sarcolemmal Ca2+ fluxes in isolated rat ventricular myocytes during spotaneous Ca2+ release. J Physiol 501: 3–16, 1997.[Abstract/Free Full Text]
  11. Dukes H. Dukes' Physiology of Domestic Animals. Ithaca, NY: Cornell Univ. Press, 1993.
  12. Eisner DA, Isenberg G, and Sipido KR. Normal and pathological excitation-contraction coupling in the heart–an overview. J Physiol 546: 3–4, 2003.[Abstract/Free Full Text]
  13. Fabiato A and Fabiato F. Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned cells. J Physiol 75: 463–505, 1979.
  14. Fabiato A. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol Cell Physiol 245: C1–C14, 1983.[Abstract/Free Full Text]
  15. Fabiato A and Fabiato F. Contractions induced by a calcium-triggered release of calcium from the sarcoplasmic reticulum of single skinned cardiac cells. J Physiol 249: 469–495, 1975.[Abstract/Free Full Text]
  16. Finley MR, Li Y, Hua F, Lillich J, Mitchell KE, Ganta S, Gilmour RF Jr, and Freeman LC. Expression and coassociation of ERG1, KCNQ1, and KCNE1 potassium channel proteins in horse heart. Am J Physiol Heart Circ Physiol 283: H126–H138, 2002.[Abstract/Free Full Text]
  17. Grynkiewicz G, Poenie M, and Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440–3450, 1985.[Abstract/Free Full Text]
  18. Hinch R, Eisner DA, and O'Neill SC. Inhibition of SR Ca2+ uptake increases Ca2+ efflux generated by propagating waves of Ca2+ release in isoltaed ventricular myocytes. J Physiol. In Press.
  19. Hove-Madsen L and Bers DM. Passive Ca buffering and SR Ca uptake in permeabilized rabbit ventricular myocytes. Am J Physiol Cell Physiol 264: C677–C686, 1993.[Abstract/Free Full Text]
  20. Janse MJ, Vermeulen JT, Opthof T, Coronel R, Wilms-Schopman FJ, Rademaker HM, Baartscheer A, and Dekker LR. Arrhythmogenesis in heart failure. J Cardiovasc Electrophysiol 12: 496–499, 2001.[CrossRef][ISI][Medline]
  21. Kaab S, Nuss HB, Chiamvimonvat N, O'Rourke B, Pak PH, Kass DA, Marban E, and Tomaselli GF. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res 78: 262–273, 1996.[Abstract/Free Full Text]
  22. Kaneko T, Tanaka H, Oyamada M, Kawata S, and Takamatsu T. Three distinct types of Ca2+ waves in Langendorff-perfused rat heart revealed by real time confocal microscopy. Circ Res 86: 1093–1099, 2000.[Abstract/Free Full Text]
  23. Kargacin GJ, Ali Z, and Kargacin ME. Ruthenium red reduces the Ca2+ sensitivity of Ca2+ uptake into cardiac sarcoplasmic reticulum. Pflügers Arch 436: 338–342, 1998.[CrossRef][ISI][Medline]
  24. Kass RS, Tsien RW, and Weingart R. Ionic basis of transient inward current induced by strophanthidin in cardiac Purkinje fibres. J Physiol 281: 209–226, 1978.[Abstract/Free Full Text]
  25. Keizer J, Smith GD, Ponce-Dawson S, and Pearson JE. Saltatory propagation of Ca2+ waves by Ca2+ sparks. Biophys J 75: 595–600, 1998.[Medline]
  26. Kort AA, Capagrossi MC, and Lakatta EG. Frequency, amplitude and propagation veolcity of spontaneous Ca2+ dependent contractile waves in intact adult rat cardiac muscle and isolated myocytes. Circ Res 57: 844–855, 1985.[Abstract/Free Full Text]
  27. Kurihara S and Sakai T. Effects of rapid cooling on mechanical and electrical responses in ventricular muscle of guinea-pig. J Physiol 361: 361–378, 1985.[Abstract/Free Full Text]
  28. Lederer WJ and Tsien RW. Transient inward current underlying arrhythmogenic effects of cardiotonic steroids in Purkinje fibres. J Physiol 263: 73–100, 1976.[Abstract/Free Full Text]
  29. Loughrey CM, MacEachern KE, and Smith GL. The relationship between intracellular [Ca2+] and Ca2+ wave characteristics in permeabilised cardiomyocytes from the rabbit. J Physiol 543: 859–870, 2002.[Abstract/Free Full Text]
  30. Loughrey CM, MacEachern KE, Cooper J, and Smith GL. Measurement of the dissociation constant of Fluo-3 for Ca2+ in isolated rabbit cardiomyocytes using Ca2+ wave characteristics. Cell Calcium 34: 1–9, 2003.[CrossRef][ISI][Medline]
  31. Lukyanenko V and Gyorke S. Ca2+ sparks and Ca2+ waves in saponin-permeabilized rat ventricular myocytes. J Physiol 521: 575–585, 1999.[Abstract/Free Full Text]
  32. Lukyanenko V, Subramanian S, Gyorke I, Wiesner TF, and Gyorke S. The role of luminal Ca2+ in the generation of Ca2+ waves in rat ventricular myocytes. J Physiol 518: 173–186, 1999.[Abstract/Free Full Text]
  33. Lukyanenko V, Viatchenko-Karpinski S, Smirnov A, Wiesner TF, and Gyorke S. Dynamic regulation of sarcoplasmic reticulum calcium content and release by luminal calcium sensitive leak in rat ventricular myocytes. Biophys J 81: 785–798, 2001.[ISI][Medline]
  34. Macianskiene R, Bito V, Raeymaekers L, Brandts B, Sipido KR, and Mubagwa K. Action potential changes associated with a slowed inactivation of cardiac voltage-gated sodium channels by KB130015. Br J Pharmacol 139: 1469–1479, 2003.[CrossRef][ISI][Medline]
  35. Maier LS, Bers DM, and Pieske B. Differences in Ca2+-handling and sarcoplasmic reticulum Ca2+ content in isolated rat and rabbit myocardium. J Mol Cell Cardiol 32: 2249–2258, 2000.[CrossRef][ISI][Medline]
  36. McIntosh MA, Cobbe SM, and Smith GL. Heterogeneous changes in action potential and intracellular Ca2+ in left ventricular myocyte subtypes from rabbits with heart failure. Cardiovasc Res 45: 397–409, 2000.[Abstract/Free Full Text]
  37. Meixner R, Hornicke H, and Ehrlein H. Oxygen Consumption, Pulmonary Ventilation, and Heart Rate of Riding Horses During Walk, Trot, and Gallop. Fayetteville, AR: Univ. of Arkansas Press, 1981.
  38. Miller DJ and Smith GL. EGTA purity and the buffering of calcium ions in physiological solutions. Am J Physiol Cell Physiol 246: C160–C166, 1984.[Abstract/Free Full Text]
  39. Nabauer M and Kaab S. Potassium channel downregulation in heart failure. Cardiovasc Res 37: 324–334, 1998.[CrossRef][ISI][Medline]
  40. Ng GA, Hicks MN, Cobbe SM, and Smith GL. Depressed inotropic response to increased preload in rabbit hearts with left-ventricular dysfunction induced by chronic myocardial infarction. Pflügers Arch 444: 513–522, 2002.[CrossRef][ISI][Medline]
  41. O'Rourke B, Kass DA, Tomaselli GF, Kaab S, Tunin R, and Marban E. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure. I: experimental studies. Circ Res 84: 562–570, 1999.[Abstract/Free Full Text]
  42. Overend CL, Eisner DA, and O'Neill SC. The effect of tetracaine on spontaneous Ca2+ release and sarcoplasmic reticulum calcium content in rat ventricular myocytes. J Physiol 502: 471–479, 1997.[Abstract/Free Full Text]
  43. Patteson M. Equine Cardiology. Oxford, UK: Blackwell, 1996.
  44. Pieske B, Kretschmann B, Meyer M, Holubarsch C, Weirich J, Posival H, Minami K, Just H, and Hasenfuss G. Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation 92: 1169–1178, 1995.[Abstract/Free Full Text]
  45. Rossner KL and Sachs HG. Electrophysiological study of Syrian hamster hereditary cardiomyopathy. Cardiovasc Res 12: 436–443, 1978.[ISI][Medline]
  46. Smith GL and Miller DJ. Potentiometric measurements of stoichiometric and apparent affinity constants of EGTA for protons and divalent ions including calcium. Biochim Biophys Acta 839: 287–299, 1985.[Medline]
  47. Smith G and O'Neill SC. A comparison of the effects of ATP and tetracaine on spontaneous calcium release from rat permeabilized cardiac myocytes. J Physiol 534: 37–47, 2001.[Abstract/Free Full Text]
  48. Steele DS and Smith GL. Effects of 2,3-butanedione monoxime on sarcoplasmic reticulum of saponin-treated rat cardiac muscle. Am J Physiol Heart Circ Physiol 265: H1493–H1500, 1993.[Abstract/Free Full Text]
  49. Takamatsu T and Wier WG. Calcium waves in mammalian heart: quantification of orgin, magnitude, waveform, and velocity. FASEB J 4: 1519–1525, 1990.[Abstract]
  50. Terentyev D, Viatchenko-Karpinski S, Gyorke I, Volpe P, Williams SC, and Gyorke S. Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: mechanism for hereditary arrhythmia. Proc Natl Acad Sci USA 100: 11759–11764, 2003.[Abstract/Free Full Text]
  51. Trafford AW, Lipp P, O'Neill SC, Niggli E, and Eisner DA. Propagating calcium waves intiated by local caffeine application in rat ventricular myocytes. J Physiol 489: 319–326, 1995.[Abstract/Free Full Text]
  52. Vermeulen JT, McGuire MA, Opthof T, Coronel R, de Bakker JM, Klopping C, and Janse MJ. Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts. Cardiovasc Res 28: 1547–1554, 1994.[ISI][Medline]
  53. Volders PG, Kulcsar A, Vos MA, Sipido KR, Wellens HJ, Lazzara R, and Szabo B. Similarities between early and delayed afterdepolarizations induced by isoproterenol in canine ventricular myocytes. Cardiovasc Res 34: 348–359, 1997.[Abstract/Free Full Text]
  54. Wier WG, Cannell MB, Berlin JR, Marban E, and Lederer WJ. Cellular and subcellular heterogeneity of [Ca2+]i in single heart cells revealed by fura-2. Science 235: 325–328, 1987.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
B. Rosati, M. Dong, L. Cheng, S.-R. Liou, Q. Yan, J. Y. Park, E. Shiang, M. Sanguinetti, H.-S. Wang, and D. McKinnon
Evolution of ventricular myocyte electrophysiology
Physiol Genomics, November 12, 2008; 35(3): 262 - 272.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
V. Sathish, A. Xu, M. Karmazyn, S. M. Sims, and N. Narayanan
Mechanistic basis of differences in Ca2+-handling properties of sarcoplasmic reticulum in right and left ventricles of normal rat myocardium
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H88 - H96.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/3/H1149    most recent